Tadawul trade advice (B): Saudi healthcare stock | 5-6% gain | KSA stock trading idea on 20 Apr 2026

Date
April 20, 2026
Analysed By
Naranj Capital Research Desk
Stock Market
Tadawul, Saudi Arabia
  • Buy
  • Buy
    Range
  • Target
  • Stoploss
  • Upside
    Potential
  • Trade
    Duration
  • Middle East Healthcare
  • 38 - 38.5
  • 40.5 - 41
  • Below 37
  • 5% - 6%
  • 12 - 14 Days
  • Buy Middle East Healthcare
  • Buy
    Range
    38 - 38.5
  • Target 40.5 - 41
  • Stoploss Below 37
  • Upside
    Potential
    5% - 6%
  • Trade
    Duration
    12 - 14 Days
  • Buy
  • Buy
    Range
  • Target
  • Stoploss
  • Upside
    Potential
  • Trade
    Duration
  • Middle East Healthcare
  • 38 - 38.5
  • 40.5 - 41
  • Below 37
  • 5% - 6%
  • 12 - 14 Days
  • Locked Image
    Locked Image
    Locked Image
    Locked Image

    5% - 6%

    12 - 14 Days

  • Buy
    Middle East Healthcare
  • Buy
    Range
    38 - 38.5
  • Target
    40.5 - 41
  • Stoploss
    Below 37
  • Upside
    Potential
    5% - 6%
  • Trade
    Duration
    12 - 14 Days
  • Locked Image
    Locked Image
    Locked Image
    Locked Image

    5% - 6%

    12 - 14 Days

    * Once the first target hit, reset the StopLoss at your buying price.
    * Trade durations are approximate; actual holding period may vary.

    Tadawul 4009 : Middle East Healthcare - Stock Overview

  • Tadawul code
  • Stock Name
  • Sector
  • 52 Weeks High
  • 52 Weeks Low
  • 4009
  • Saudi German Health
  • Health Care
  • 71.80
  • 28.66
  • Tadawul code 4009
  • Stock Name Saudi German Health
  • Sector Health Care
  • 52 Weeks High 71.80
  • 52 Weeks Low 28.66
  • Company profile

    Middle East Healthcare Company is a healthcare company that runs hospitals under the Saudi German Hospital brand in Saudi Arabia and other countries.

    It manages hospitals and medical centers, including labs, radiology, physiotherapy, and pharmacies. It also develops healthcare projects and related facilities.

    Founded in 1988 and based in Jeddah, it is a subsidiary of Bait Al Batterjee Medical Co. Ltd.

  • Tadawul 4009 : Middle East Healthcare vs TASI - Relative Performance

    The image highlights Middle East Healthcare Company's performance over the last year versus TASI.
    Relative Performance - Last 1 Year
    SAUDI GERMAN HEALTH —   TASI —

  • Tadawul 4009 : Middle East Healthcare - Price Performance

    Middle East Healthcare - Price Performance
    Middle East Healthcare - Price Performance

  • Tadawul 4009 : Middle East Healthcare - Technical Analysis (Daily)

    Middle East Healthcare - Daily Technical Analysis
    Middle East Healthcare - Daily Technical Analysis

    • The stock is currently trading within a falling wedge pattern.
    • After taking support at the lower trendline, it has formed an inverted head & shoulders pattern.
    • With a fresh breakout in place, the stock now appears positioned for a continued upside move in the near term.
  • Tadawul 4009 : Middle East Healthcare - Oscillators

    Indicator Value Zone
    RSI-14 67.09 Neutral
    CCI-14 199.16 Overbought
    Stochastic RSI 80.09 Overbought
    ROC 12.21 Positive
    William %R -8.8 Overbought

  • Tadawul 4009 : Middle East Healthcare - Exponential Moving Averages (EMAs)

    EMA Value Stock Position
    5 EMA 37.55 Above
    10 EMA 36.92 Above
    20 EMA 35.94 Above
    50 EMA 34.96 Above
    100 EMA 37.40 Above
    200 EMA 43.81 Below

  • Conclusion - Tadawul 4009 : Middle East Healthcare Stock Price Forecast

    Based on our Saudi Tadawul stock trading advice, Middle East Healthcare stock price target will be SAR 40.5 - SAR 41 in the next 12-14 trading sessions.

  • Share with
    0 0 votes
    Article Rating
    Subscribe
    Notify of
    guest
    0 Comments
    Inline Feedbacks
    View all comments

    Join Our Telegram Channel for Saudi Stock Market Update

    Saudi Stocks Analysis

    Details of Arijit Banerjee

    Arijit Banerjee CMT CFTe is a seasoned expert in the financial industry, boasting decades of experience in trading, investment, and wealth management. As the founder and chief strategist of Naranj Capital, he’s built a reputation for providing insightful research analysis to guide investment decisions.

    Arijit’s credentials are impressive, holding both the Chartered Market Technician (CMT) and Certified Financial Technician (CFTe) designations. These certifications demonstrate his expertise in technical analysis and financial markets.

    Through Naranj Capital, Arijit shares his market insights and research analysis, offering actionable advice for investors. His work is featured on platforms like TradingView, where he publishes detailed analysis and recommendations.

    If you’re interested in learning more about Arijit’s work or Naranj Capital’s services, you can reach out to them directly through their website